CD4 and breast carcinoma: Upon analysis of treated and untreated breast cancer patients to determine whether it was treatment affecting the patients’ immunophenotypes, it was found that there were no significant differences between the phenotypes of untreated patients and healthy donors, while patients who previously received chemotherapy or CDKi had a lower percentage of pDC and CD4+ T cells, and a higher percentage of monocytes.